Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/01/2025 10:29 PDT] Anteris Technologies Global Corp. (NASDAQ:AVR), Down By 100% ($5.39) From $5.39 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/29/2025 07:39 PDT] AVR Expected to Trade Down After Bearish Patterns Develop
• [04/24/2025 10:29 PDT] AVR SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [04/11/2025 21:16 PDT] Market Maker Surveillance Report. AVR, Losing Stocks With Lowest Price Friction For Friday, April 11th 2025
• [03/24/2025 10:29 PDT] Anteris Technologies Global Corp. (NASDAQ:AVR), Down By 100% ($5.76) From $5.76 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/21/2025 07:12 PDT] AVR Expected to Trade Down Short Term
• [03/20/2025 10:29 PDT] AVR SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.